Kovack Advisors, Inc. Xenon Pharmaceuticals Inc. Transaction History
Kovack Advisors, Inc.
- $988 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
222Shares Held
73.1MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$230 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$185 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$154 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$153 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$136 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.66B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...